{"id":368723,"date":"2021-02-05T23:35:01","date_gmt":"2021-02-06T07:35:01","guid":{"rendered":"https:\/\/nai500.com\/blog\/2021\/02\/clover-shares-close-up-nearly-6-after-chamath-palihapitiya-rebukes-hindenburg-report-bristol-myers-squibb-wins-fda-approval-for-lymphoma-treatment-breyanzi\/"},"modified":"2021-02-06T01:25:07","modified_gmt":"2021-02-06T09:25:07","slug":"%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8-clover-health-%e8%82%a1%e5%83%b9%e6%94%b6%e7%9b%a4%e4%b8%8a%e6%bc%b2%e8%bf%91%e7%99%be%e6%99%82%e7%be%8e%e6%96%bd%e8%b2%b4%e5%af%b6%e6%b7%8b","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2021\/02\/%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8-clover-health-%e8%82%a1%e5%83%b9%e6%94%b6%e7%9b%a4%e4%b8%8a%e6%bc%b2%e8%bf%91%e7%99%be%e6%99%82%e7%be%8e%e6%96%bd%e8%b2%b4%e5%af%b6%e6%b7%8b\/","title":{"rendered":"\u91ab\u7642\u4fdd\u5065\u7cbe\u9078&#8211;Clover Health\u80a1\u50f9\u6536\u76e4\u4e0a\u6f32\u8fd16%\uff1b\u767e\u6642\u7f8e\u65bd\u8cb4\u5bf6\u6dcb\u5df4\u7624\u7642\u6cd5Breyanzi\u7372\u5f97\u6279\u51c6"},"content":{"rendered":"<h2>Clover Health<strong>\u80a1\u50f9\u6536\u76e4\u4e0a\u6f32\u8fd1<\/strong><strong>6%<\/strong><\/h2>\n<p>\u652f\u6301Clover Health\uff08NASDAQ:<a href=\"https:\/\/seekingalpha.com\/symbol\/CLOV?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">CLOV<\/a>\uff09\u7684\u8457\u540d\u6295\u8cc7\u8005Chamath Palihapitiya\u6628\u5929<a href=\"https:\/\/twitter.com\/chamath\/status\/1357791464768430082?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">\u5728Twitter\u4e0a\u5c0d<\/a>Hindenburg Research\u767c\u4f48\u7684\u4e00\u4efd<a href=\"https:\/\/seekingalpha.com\/news\/3658363-clover-heath-drops-after-hindenburg-research-releases-new-short-call?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">\u5531\u7a7a\u5831\u544a\u505a\u51fa\u4e86<\/a><a href=\"https:\/\/twitter.com\/chamath\/status\/1357791464768430082?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">\u56de\u61c9<\/a>\u3002<\/p>\n<p>Palihapitiya\u5728\u56de\u61c9\u4e2d\u8aaa\uff0c\u9019\u4efd\u5831\u544a&#8221;\u5145\u65a5\u8457\u4eba\u8eab\u653b\u64ca\u3001\u55ae\u8584\u7684\u4e8b\u5be6\u548c\u865b\u5f35\u8072\u52e2&#8221;\u3002<\/p>\n<p>&#8220;\u5c0d\u65bc\u8208\u767b\u5821\u4f86\u8aaa\uff0c\u9019\u6a23\u7684\u4fe1\u606f\u8acb\u6c42\uff0c\u4e26\u5229\u7528\u5b83\u4f86\u63cf\u8ff0\u4e00\u500b\u7006\u8077\u548c\u6b3a\u8a50\u7684\u6848\u4ef6\u662f\u865b\u5047\u7684\u3002&#8221;<\/p>\n<p>\u95dc\u65bc\u505a\u7a7a\u8005\uff0c\u793e\u6703\u8cc7\u672c\u9996\u5e2d\u57f7\u884c\u5b98\u6307\u51fa\uff0c&#8221;\u4ed6\u5011\u61c9\u8a72\u4ecd\u7136\u662f\u8cc7\u672c\u5e02\u5834\u7684\u4e00\u90e8\u5206\uff0c\u4e26\u627f\u8a8d\u5728\u67d0\u4e9b\u60c5\u6cc1\u4e0b\u4ed6\u5011\u53ef\u4ee5\u8b58\u5225\u771f\u6b63\u7684\u7570\u5e38\u60c5\u6cc1\u7684\u89c0\u9ede\u3002\u9019\u88e1\u7684\u60c5\u6cc1\u4e26\u975e\u5982\u6b64&#8221;\u3002<\/p>\n<p>Clover Health\u80a1\u50f9\u6536\u76e4\u4e0a\u6f325.7%\u81f312.93\u7f8e\u5143\u3002<\/p>\n<h2><strong>\u767e\u6642\u7f8e\u65bd\u8cb4\u5bf6\u7372<\/strong><strong>FDA<\/strong><strong>\u6279\u51c6\u6cbb\u7642\u6dcb\u5df4\u7624\u7684<\/strong><strong>Breyanzi<\/strong><strong>\u7642\u6cd5<\/strong><\/h2>\n<p>FDA\u5df2\u6279\u51c6\u767e\u6642\u7f8e\u65bd\u8cb4\u5bf6\uff08NYSE:<a href=\"https:\/\/seekingalpha.com\/symbol\/BMY?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">BMY\uff09<\/a>\u516c\u53f8\u7684Breyanzi\uff08\u5229\u7d22\u5361\u5e03\u6c40maraleucel\uff1bliso-cel\uff09\u7528\u65bc\u5c0d\u81f3\u5c11\u5169\u7a2e<a href=\"https:\/\/www.prnewswire.com\/news-releases\/fda-approves-new-treatment-for-adults-with-relapsed-or-refractory-large-b-cell-lymphoma-301223275.html?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">\u5176\u4ed6\u985e\u578b\u7cfb\u7d71\u6cbb\u7642<\/a>\u7121\u53cd\u61c9\u6216\u5fa9\u767c\u7684\u67d0\u4e9b\u985e\u578b\u5927B\u7d30\u80de\u6dcb\u5df4\u7624\u60a3\u8005<a href=\"https:\/\/www.prnewswire.com\/news-releases\/fda-approves-new-treatment-for-adults-with-relapsed-or-refractory-large-b-cell-lymphoma-301223275.html?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">\u3002<\/a><\/p>\n<p>Breyanzi\u662f\u7b2c\u4e09\u7a2e\u7372\u5f97FDA\u6279\u51c6\u7684\u57fa\u56e0\u7642\u6cd5\uff0c\u7528\u65bc\u6cbb\u7642\u67d0\u4e9b\u985e\u578b\u7684\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff0c\u5305\u62ec\u5f4c\u6f2b\u6027\u5927B\u7d30\u80de\u6dcb\u5df4\u7624\uff08&#8221;DLBCL&#8221;\uff09\uff0c\u9019\u662f\u6210\u4eba\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u4e2d\u6700\u5e38\u898b\u7684\u5f62\u5f0f\u3002<\/p>\n<h2><strong>\u7f8e\u570b<\/strong><strong>FDA<\/strong><strong>\u6279\u51c6<\/strong><strong>Ukoniq<\/strong><strong>\u5f8c\uff0c<\/strong><strong>TG Therapeutics<\/strong><strong>\u6500\u5347\u3002<\/strong><\/h2>\n<p>\u5728<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/213176s000lbl.pdf?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">FDA\u5ba3\u4f48\u6279\u51c6<\/a>Ukoniq(umbralisib)\u7528\u65bc\u6cbb\u7642\u4e4b\u524d\u81f3\u5c11\u63a5\u53d7\u904e\u4e00\u7a2e\u57fa\u65bc\u6297CD20\u7684\u65b9\u6848\u7684\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u908a\u7de3\u5340\u6dcb\u5df4\u7624\u7684\u6210\u4eba\u5f8c\uff0cTG Therapeutics(NASDAQ:<a href=\"https:\/\/seekingalpha.com\/symbol\/TGTX?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link\">TGTX<\/a>)\u98c6\u5347\u4e86\u7d046.1%\u3002<\/p>\n<p>\u6b64\u5916\uff0cUkoniq\u9084\u88ab\u6279\u51c6\u7528\u65bc\u6cbb\u7642\u4e4b\u524d\u81f3\u5c11\u63a5\u53d7\u904e\u4e09\u7dda\u7cfb\u7d71\u6cbb\u7642\u7684\u5fa9\u767c\u6216\u96e3\u6cbb\u6027\u6ffe\u6ce1\u6027\u6dcb\u5df4\u7624\u6210\u4eba\u60a3\u8005\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Clover Health\u80a1\u50f9\u6536\u76e4\u4e0a\u6f32\u8fd16% \u652f\u6301Clover Health\uff08NASDAQ:CLOV\uff09\u7684\u8457\u540d\u6295 [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":368717,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,644,564],"class_list":["post-368723","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-644","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/368723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=368723"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/368723\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/368717"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=368723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=368723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=368723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}